项目名称: 新型NOTCH1抗体-多壁碳纳米管- γ分泌酶抑制剂复合物抗急性T淋巴细胞白血病的研究
项目编号: No.81200381
项目类型: 青年科学基金项目
立项/批准年度: 2013
项目学科: 医学一处
项目作者: 刘胡丹
作者单位: 华中科技大学
项目金额: 23万元
中文摘要: 急性T淋巴细胞白血病(T-ALL)是一种常见的儿童恶性肿瘤,严重威胁青少年健康。文献报道,NOTCH1信号通路异常激活对T-ALL的发生发展至关重要,T-ALL细胞高度依赖NOTCH1的活性生长增殖,故以γ-分泌酶抑制剂(GSI)为代表的NOTCH1抑制剂是目前最有前景的分子靶向药物,然而其组织非专一性引起的毒副作用不容忽视。为克服现有的局限性,本课题提出一种纳米复合物给药系统的策略: 以聚乙二醇功能化的多壁碳纳米管运载GSI分子,同时结合 NOTCH1单克隆抗体以提供靶向。拟采用纳米生物学,分子生物学,细胞生物学以及模式动物等学科交叉的研究方法,1)构建、表征上述载药系统;2)分析复合物抑制NOTCH1活性和T-ALL细胞系的生长情况;3)考察复合物在小鼠模型体内的分布和抗白血病活性。该项目将为探索一个新型、高效、专一、低毒并具有实用前景的T-ALL治疗方案提供新思路。
中文关键词: 靶向治疗;多壁碳纳米管;NOTCH 信号通路;Wnt 信号通路;天然产物
英文摘要: Acute T-cell lymphoblastic leukemia (T-ALL) is an aggressive and life-threatening cancer, commonly diagosed in children and adolescents. More and more evidence suggest aberrant NOTCH1 signaling plays a pivotal role in the pathogenesis of acute T-cell lymphoblastic leukemia (T-ALL). As NOTCH1-induced T-ALL cells depend on NOTCH1 signaling for their proliferation, growth and survival, the γ-secretase inhibitor(GSI), one common NOTCH1 inhibitor, is viewed as the most promising agent to treat T-ALL. However, GSI manifested intolerable toxicity in human patients due to its nonspecific targeting. To extenuate the adverse effect, we propose a novel nano-composit drug delivery system: GSI molecules will be loaded onto polyethylene glycol (PEG)-coated multi-wall carbon nanotubes (MWCNTs), to which anti-NOTCH1 monoclonal antibody will be also conjugated. Combining approaches of nanobiology, molecular biology, cell biology and animal modeling, we plan to (1) synthesize and characaterize the NOTCH1 antibody-MWCNT-GSI composit;(2) analyze its inhibitory function of NOTCH1 signaling and T-ALL cell proliferation;(3) study the anti-leukemic activity and in vivo distribution in T-ALL murine models. Our study aims to build the foundation for ultimately achieving a better therapeutic strategy of improved targeting,optimized activi
英文关键词: Targeted therapy;Multi-wall carbon nanotubes;NOTCH signaling;Wnt signaling;Natural product